These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 33233664)

  • 21. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
    Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
    EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.
    Hoda MA; Mohamed A; Ghanim B; Filipits M; Hegedus B; Tamura M; Berta J; Kubista B; Dome B; Grusch M; Setinek U; Micksche M; Klepetko W; Berger W
    J Thorac Oncol; 2011 May; 6(5):852-63. PubMed ID: 21358348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced antitumor therapy by inhibition of p21waf1 in human malignant mesothelioma.
    Lazzarini R; Moretti S; Orecchia S; Betta PG; Procopio A; Catalano A
    Clin Cancer Res; 2008 Aug; 14(16):5099-107. PubMed ID: 18698027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of malignant pleural mesothelioma.
    Jaurand MC; Fleury-Feith J
    Respirology; 2005 Jan; 10(1):2-8. PubMed ID: 15691231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
    Beije N; Kraan J; den Bakker MA; Maat APWM; van der Leest C; Cornelissen R; Van NM; Martens JWM; Aerts JGJV; Sleijfer S
    Cell Oncol (Dordr); 2017 Oct; 40(5):511-519. PubMed ID: 28577209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesothelioma.
    Moriya M; Yamada T; Tamura M; Ishikawa D; Hoda MA; Matsumoto I; Klepetko W; Oda M; Yano S; Watanabe G
    Oncol Rep; 2014 Mar; 31(3):1109-15. PubMed ID: 24378576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in malignant pleural mesothelioma (MPM) cells.
    Amatori S; Papalini F; Lazzarini R; Donati B; Bagaloni I; Rippo MR; Procopio A; Pelicci PG; Catalano A; Fanelli M
    Lung Cancer; 2009 Nov; 66(2):184-90. PubMed ID: 19233506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing.
    Laure A; Rigutto A; Kirschner MB; Opitz L; Grob L; Opitz I; Felley-Bosco E; Hiltbrunner S; Curioni-Fontecedro A
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma.
    Yang H; Xu D; Schmid RA; Peng RW
    Ther Adv Med Oncol; 2020; 12():1758835920971421. PubMed ID: 33240401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of BCL-2 family proteins and therapeutic potential of BH3-mimetics in malignant pleural mesothelioma.
    Arulananda S; Lee EF; Fairlie WD; John T
    Expert Rev Anticancer Ther; 2021 Apr; 21(4):413-424. PubMed ID: 33238762
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical risk factor analysis of bilateral vestibular schwannoma's growth pattern inconsistency in individual NF2 patients.
    Li P; Li S; Wang Y; Zhao F; Wang Z; Wang X; Wang B; Yang Z; Liu P
    Clin Neurol Neurosurg; 2021 Jan; 200():106365. PubMed ID: 33243701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis.
    Guo L; Li S; Qian B; Wang Y; Duan R; Jiang W; Kang Y; Dou Y; Yang G; Shen L; Wang J; Liang T
    Comput Struct Biotechnol J; 2020; 18():3243-3254. PubMed ID: 33240468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pleurectomy Decortication in the Treatment of Malignant Pleural Mesothelioma: Encouraging Results and Novel Prognostic Implications Based on Experience in 355 Consecutive Patients.
    Lapidot M; Gill RR; Mazzola E; Freyaldenhoven S; Swanson SJ; Jaklitsch MT; Sugarbaker DJ; Bueno R
    Ann Surg; 2022 Jun; 275(6):1212-1220. PubMed ID: 33278174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofibromatosis 2: rare constellation of findings with extensive cranial nerve involvement.
    Hiremath R; Dakshin V; Agrawal S
    Radiol Case Rep; 2021 Jan; 16(1):157-165. PubMed ID: 33240459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The FBXL family of F-box proteins: variations on a theme.
    Mason B; Laman H
    Open Biol; 2020 Nov; 10(11):200319. PubMed ID: 33234069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell and extracellular matrix interaction models in benign mesothelial and malignant pleural mesothelioma cells in 2D and 3D in-vitro.
    Jagirdar RM; Papazoglou ED; Pitaraki E; Kouliou OA; Rouka E; Giannakou L; Giannopoulos S; Sinis SI; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
    Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):543-552. PubMed ID: 33336399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Programmed cell death 1 ligand 1 (PD-L1) expression is associated with poor prognosis of malignant pleural mesothelioma patients with good performance status.
    Rrapaj E; Giacometti L; Spina P; Salvo M; Baselli GA; Veggiani C; Rena O; Trisolini E; Boldorini RL
    Pathology; 2021 Jun; 53(4):462-469. PubMed ID: 33272690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML.
    Sekeres MA; Watts J; Radinoff A; Sangerman MA; Cerrano M; Lopez PF; Zeidner JF; Campelo MD; Graux C; Liesveld J; Selleslag D; Tzvetkov N; Fram RJ; Zhao D; Bell J; Friedlander S; Faller DV; Adès L
    Leukemia; 2021 Jul; 35(7):2119-2124. PubMed ID: 33483617
    [No Abstract]   [Full Text] [Related]  

  • 39. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.
    Olaizola P; Lee-Law PY; Fernandez-Barrena MG; Alvarez L; Cadamuro M; Azkargorta M; O'Rourke CJ; Caballero-Camino FJ; Olaizola I; Macias RIR; Marin JJG; Serrano-Maciá M; Martinez-Chantar ML; Avila MA; Aspichueta P; Calvisi DF; Evert M; Fabris L; Castro RE; Elortza F; Andersen JB; Bujanda L; Rodrigues PM; Perugorria MJ; Banales JM
    J Hepatol; 2022 Jul; 77(1):177-190. PubMed ID: 35217064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cullin 4B Ubiquitin Ligase Is Important for Cell Survival and Regulates TGF-β1 Expression in Pleural Mesothelioma.
    Kreienbühl J; Changkhong S; Orlowski V; Kirschner MB; Opitz I; Meerang M
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.